Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy

Detalhes bibliográficos
Autor(a) principal: Anversa Sugisaka, Ana Carolina
Data de Publicação: 2020
Outros Autores: Mari Salvi Andrzejevski, Vânia, Rotta, Inajara
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1079
Resumo: Introduction: The low adherence to treatment with oral antineoplastic agents reflects the need for measures to facilitate compliance with therapy, such as providing educational materials. Objective: Develop and validate leaflets guiding the use of tamoxifen, anastrozole and capecitabine for breast cancer treatment. Method: To define the leaflet´s content, the MEDLINE and UpToDate databases and national and international guidelines were consulted, adopting language accessible to the public. The validation was performed by oncology specialists through the Delphi method, considering the attributes of language, content and appearance. A satisfactory consensus was reached when the interquartile range (IR) was ≤ 1, obtained through a Likert scale ranging from 1 to 5. Results: The group of specialists was formed by 29 professionals. In the first round an IR of 1.43 was obtained; 1.14 and 1.43, and, in the second round, 0.71; 1.04 and 0.79 for language, content and appearance, respectively. Conclusion: It is expected that these tools promote better patient perception and adherence to treatment, contributing to self-management of pharmacotherapy.
id INCA-1_83eef15695b6af18bedbb65827d00ecf
oai_identifier_str oai:rbc.inca.gov.br:article/1079
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone TherapyValidación de Materiales Educativos para Orientación de Pacientes en Tratamiento de Cáncer de Mama con Terapia HormonalValidação de Materiais Educativos para Orientação de Pacientes em Tratamento de Câncer de Mama com HormonioterapiaNeoplasias da Mama/tratamento farmacológicoEstudos de ValidaçãoEducação em SaúdeMateriais EducativosAssistência FarmacêuticaBreast Neoplasms/drug therapyValidation StudyHealth EducationEducational and Promotional MaterialsPharmaceutical ServicesNeoplasias de la Mama/tratamiento farmacológicoEstudios de ValidaciónEducación en SaludMateriales Educativos y de DivulgaciónServicios FarmacéuticosIntroduction: The low adherence to treatment with oral antineoplastic agents reflects the need for measures to facilitate compliance with therapy, such as providing educational materials. Objective: Develop and validate leaflets guiding the use of tamoxifen, anastrozole and capecitabine for breast cancer treatment. Method: To define the leaflet´s content, the MEDLINE and UpToDate databases and national and international guidelines were consulted, adopting language accessible to the public. The validation was performed by oncology specialists through the Delphi method, considering the attributes of language, content and appearance. A satisfactory consensus was reached when the interquartile range (IR) was ≤ 1, obtained through a Likert scale ranging from 1 to 5. Results: The group of specialists was formed by 29 professionals. In the first round an IR of 1.43 was obtained; 1.14 and 1.43, and, in the second round, 0.71; 1.04 and 0.79 for language, content and appearance, respectively. Conclusion: It is expected that these tools promote better patient perception and adherence to treatment, contributing to self-management of pharmacotherapy.Introducción: La baja adherencia al tratamiento con agentes antineoplásicos orales refleja la necesidad de medidas para facilitar el cumplimiento de la terapia, como la provisión de materiales educativos. Objetivo: Desarrollar y validar folletos que guíen el uso de tamoxifeno, anastrozol y capecitabina en el tratamiento de cáncer de mama. Método: Para definir el contenido de los folletos, se consultaron las bases de datos MEDLINE y UpToDate, además de guías nacionales y internacionales, adoptando lenguaje accesible al público. La validación fue realizada por especialistas en oncología, a través del Método Delphi, considerando los atributos de lenguaje, contenido y apariencia. Se alcanzó un consenso satisfactorio cuando el rango intercuartil (RI) fue ≤ 1, obtenido utilizando escala Likert que varía de 1 a 5. Resultados: El grupo de expertos fue compuesto por 29 profesionales. En la primera ronda, se obtuvo un RI de 1.43; 1.14 y 1.43, y, en la segunda, 0.71; 1.04 y 0.79 para lenguaje, contenido y apariencia, respectivamente. Conclusión: Se espera que estas herramientas promuevan mejor percepción del paciente y adherencia al tratamiento, contribuyendo para el autocontrol de la farmacoterapia.Introdução: A baixa adesão ao tratamento com antineoplásicos orais reflete a necessidade de medidas que facilitem o cumprimento da terapia, como a provisão de materiais educativos. Objetivo: Desenvolver e validar cartilhas orientando o uso dos medicamentos tamoxifeno, anastrozol e capecitabina no tratamento do câncer de mama. Método: Para a definição do conteúdo das cartilhas, foram consultadas as bases de dados MEDLINE e UpToDate, e as diretrizes nacionais e internacionais, adotando-se linguagem acessível ao público. A validação foi feita por especialistas em oncologia, por meio do método Delphi, considerando-se os atributos de linguagem, conteúdo e aparência. Um consenso satisfatório foi atingido quando o valor de faixa interquartil (FIQ) foi ≤ 1, obtido por meio de uma escala Likert variando de 1 a 5. Resultados: O grupo de especialistas foi composto por 29 profissionais. Na primeira rodada, foi obtida uma FIQ de 1,43; 1,14 e 1,43; e, na segunda rodada, 0,71; 1,04 e 0,79 para linguagem, conteúdo e aparência, respectivamente. Conclusão: Espera-se que essas ferramentas promovam melhor percepção e adesão do paciente ao tratamento, contribuindo para a autogestão da farmacoterapia.INCA2020-09-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/107910.32635/2176-9745.RBC.2020v66n4.1079Revista Brasileira de Cancerologia; Vol. 66 No. 4 (2020): Oct./Nov./Dec.; e-051079Revista Brasileira de Cancerologia; Vol. 66 Núm. 4 (2020): oct./nov./dic.; e-051079Revista Brasileira de Cancerologia; v. 66 n. 4 (2020): out./nov./dez.; e-0510792176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/1079/739https://rbc.inca.gov.br/index.php/revista/article/view/1079/883Copyright (c) 2020 Revista Brasileira de Cancerologiainfo:eu-repo/semantics/openAccessAnversa Sugisaka, Ana CarolinaMari Salvi Andrzejevski, VâniaRotta, Inajara2021-11-29T18:30:15Zoai:rbc.inca.gov.br:article/1079Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T18:30:15Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
Validación de Materiales Educativos para Orientación de Pacientes en Tratamiento de Cáncer de Mama con Terapia Hormonal
Validação de Materiais Educativos para Orientação de Pacientes em Tratamento de Câncer de Mama com Hormonioterapia
title Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
spellingShingle Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
Anversa Sugisaka, Ana Carolina
Neoplasias da Mama/tratamento farmacológico
Estudos de Validação
Educação em Saúde
Materiais Educativos
Assistência Farmacêutica
Breast Neoplasms/drug therapy
Validation Study
Health Education
Educational and Promotional Materials
Pharmaceutical Services
Neoplasias de la Mama/tratamiento farmacológico
Estudios de Validación
Educación en Salud
Materiales Educativos y de Divulgación
Servicios Farmacéuticos
title_short Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
title_full Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
title_fullStr Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
title_full_unstemmed Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
title_sort Validation of Educational Materials to Guide Patients on Breast Cancer Treatment with Hormone Therapy
author Anversa Sugisaka, Ana Carolina
author_facet Anversa Sugisaka, Ana Carolina
Mari Salvi Andrzejevski, Vânia
Rotta, Inajara
author_role author
author2 Mari Salvi Andrzejevski, Vânia
Rotta, Inajara
author2_role author
author
dc.contributor.author.fl_str_mv Anversa Sugisaka, Ana Carolina
Mari Salvi Andrzejevski, Vânia
Rotta, Inajara
dc.subject.por.fl_str_mv Neoplasias da Mama/tratamento farmacológico
Estudos de Validação
Educação em Saúde
Materiais Educativos
Assistência Farmacêutica
Breast Neoplasms/drug therapy
Validation Study
Health Education
Educational and Promotional Materials
Pharmaceutical Services
Neoplasias de la Mama/tratamiento farmacológico
Estudios de Validación
Educación en Salud
Materiales Educativos y de Divulgación
Servicios Farmacéuticos
topic Neoplasias da Mama/tratamento farmacológico
Estudos de Validação
Educação em Saúde
Materiais Educativos
Assistência Farmacêutica
Breast Neoplasms/drug therapy
Validation Study
Health Education
Educational and Promotional Materials
Pharmaceutical Services
Neoplasias de la Mama/tratamiento farmacológico
Estudios de Validación
Educación en Salud
Materiales Educativos y de Divulgación
Servicios Farmacéuticos
description Introduction: The low adherence to treatment with oral antineoplastic agents reflects the need for measures to facilitate compliance with therapy, such as providing educational materials. Objective: Develop and validate leaflets guiding the use of tamoxifen, anastrozole and capecitabine for breast cancer treatment. Method: To define the leaflet´s content, the MEDLINE and UpToDate databases and national and international guidelines were consulted, adopting language accessible to the public. The validation was performed by oncology specialists through the Delphi method, considering the attributes of language, content and appearance. A satisfactory consensus was reached when the interquartile range (IR) was ≤ 1, obtained through a Likert scale ranging from 1 to 5. Results: The group of specialists was formed by 29 professionals. In the first round an IR of 1.43 was obtained; 1.14 and 1.43, and, in the second round, 0.71; 1.04 and 0.79 for language, content and appearance, respectively. Conclusion: It is expected that these tools promote better patient perception and adherence to treatment, contributing to self-management of pharmacotherapy.
publishDate 2020
dc.date.none.fl_str_mv 2020-09-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1079
10.32635/2176-9745.RBC.2020v66n4.1079
url https://rbc.inca.gov.br/index.php/revista/article/view/1079
identifier_str_mv 10.32635/2176-9745.RBC.2020v66n4.1079
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1079/739
https://rbc.inca.gov.br/index.php/revista/article/view/1079/883
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Brasileira de Cancerologia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Brasileira de Cancerologia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 66 No. 4 (2020): Oct./Nov./Dec.; e-051079
Revista Brasileira de Cancerologia; Vol. 66 Núm. 4 (2020): oct./nov./dic.; e-051079
Revista Brasileira de Cancerologia; v. 66 n. 4 (2020): out./nov./dez.; e-051079
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042246110937088

Registros relacionados